Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Oncotherpapy Science Inc | 30O | Sep 27, 2024 | 0.20 | +1.56 |
OncoZenge | 8LY | Sep 27, 2024 | 0.54 | -1.65 |
ONDAS HLDGS INC. DL-,0001 | 1B8 | Sep 27, 2024 | 0.60 | -1.64 |
Onde S.A. | 0XF | Sep 27, 2024 | 2.51 | -1.57 |
Ondine Biomedical Inc | VF5 | Sep 27, 2024 | 0.06 | 0.00 |
ONE Gas, Inc. | OG9 | Sep 27, 2024 | 65.50 | -0.76 |
One Liberty Properties, Inc. | O1A | Sep 27, 2024 | 24.20 | +0.83 |
One Media iP Group Plc | 1M9 | Sep 27, 2024 | 0.04 | +22.58 |
One More Level S.A. | 1OJ | Sep 27, 2024 | 0.33 | +1.69 |
One Stop Systems, Inc. | 5MU | Sep 27, 2024 | 1.99 | +6.99 |
OneApex Limited | CWF | Sep 27, 2024 | 0.08 | 0.00 |
ONEFLOW AB | L58 | Sep 27, 2024 | 3.22 | -0.31 |
OneMain Holdings, Inc. | 0S1 | Sep 27, 2024 | 41.53 | -0.10 |
ONEOK, Inc. | ONK | Sep 27, 2024 | 79.64 | -6.27 |
OneSpan Inc. | VDY | Sep 27, 2024 | 14.40 | -0.69 |
OneSpaWorld Holdings Limited - | ORW | Sep 27, 2024 | 14.70 | -0.68 |
Onex Corp. | ONE | Sep 27, 2024 | 64.00 | +3.23 |
Ono Pharmaceutical Co. Ltd | ON4 | Sep 27, 2024 | 11.70 | -2.50 |
ONTEX GROUP NV EO -,01 | OT7 | Sep 27, 2024 | 9.01 | +1.81 |
Onto Innovation Inc. | NNM | Sep 27, 2024 | 199.00 | +4.74 |
Ontrak | HY10 | Sep 27, 2024 | 1.88 | 0.00 |
Ontrak, Inc. - 9.50% Series A Cumulative Perpetual Preferred | HY1 | Sep 27, 2024 | 0.17 | -0.59 |
Onward Medical NV | 63E | Sep 27, 2024 | 4.81 | +0.42 |
Onxeo | C4X | Sep 27, 2024 | 0.08 | 0.00 |
oOh media Limited | 0OH | Sep 27, 2024 | 0.79 | 0.00 |
OOIL | ORI1 | Sep 27, 2024 | 12.52 | +1.95 |
OP Bancorp | OP3 | Sep 27, 2024 | 10.80 | -0.92 |
OPAP (CR) | GF8 | Sep 27, 2024 | 16.18 | -0.12 |
Opawica Explorations Inc. | OE5 | Sep 27, 2024 | 0.06 | 0.00 |
Open House Co Ltd | O4H | Sep 27, 2024 | 34.40 | -2.82 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.